|
|
|
Insider
Information: |
Bailey Don M |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
699,357 |
|
Indirect Shares
|
329,463 |
|
|
Direct
Value |
$3,288,303 |
|
|
Indirect Value
|
$628,958 |
|
|
Total
Shares |
1,028,820 |
|
|
Total
Value |
$3,917,261 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Comarco Inc |
CMRO |
Chairman of the Board,... |
2006-02-06 |
64,188 |
2007-03-21 |
66,859 |
Premium* |
|
STAAR Surgical Co |
STAA |
Director |
2013-05-15 |
98,137 |
2008-11-14 |
15,000 |
Premium* |
|
Questcor Pharmaceuticals Inc |
QCOR |
See Remarks, Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Mallinckrodt plc |
MNK |
Director |
2016-03-16 |
139,149 |
2014-09-08 |
88,803 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
Director |
2016-05-13 |
88,235 |
2016-05-13 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
Director |
2016-08-29 |
247,001 |
|
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director |
2019-03-08 |
62,647 |
2024-02-08 |
158,801 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
129 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-12-13 |
4 |
S |
$53.30 |
$2,132,168 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2013-12-13 |
4 |
OE |
$5.10 |
$204,000 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-01-13 |
4 |
S |
$53.31 |
$2,145,593 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-01-13 |
4 |
OE |
$5.10 |
$204,000 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-02-13 |
4 |
OE |
$5.10 |
$204,400 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-02-13 |
4 |
S |
$69.26 |
$2,782,305 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-02-24 |
4 |
D |
$79.46 |
$5,023,461 |
D/D |
(63,220) |
278,237 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-02-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(56,834) |
341,457 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
106,000 |
398,291 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-03-13 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-03-13 |
4 |
S |
$61.67 |
$2,508,292 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-04-14 |
4 |
S |
$78.17 |
$3,186,189 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-04-14 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-05-13 |
4 |
S |
$86.69 |
$3,481,810 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-05-13 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-06-13 |
4 |
S |
$87.29 |
$3,593,085 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
President and CEO |
|
2014-06-13 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
|
2014-07-14 |
4 |
S |
$93.40 |
$3,821,700 |
I/I |
(40,000) |
99,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
|
2014-07-14 |
4 |
OE |
$5.12 |
$204,800 |
I/I |
40,000 |
139,000 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
|
2014-08-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
97,800 |
180,437 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
|
2014-08-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
140,437 |
0 |
- |
|
QCOR |
Questcor Pharmaceuticals ... |
See Remarks |
|
2014-08-13 |
4 |
S |
$91.96 |
$3,678,240 |
I/I |
(40,000) |
59,000 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2014-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
47,541 |
291,636 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2014-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
155,292 |
244,095 |
0 |
- |
|
MNK |
Mallinckrodt plc |
Director |
|
2014-08-14 |
4 |
A |
$0.00 |
$0 |
I/I |
88,803 |
88,803 |
0 |
- |
|
129 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|